A Table Topic at the 2010 American Association of Equine Practitioners Annual Meeting, held Dec. 4-8 in Baltimore, Md., addressed medical pain management. Attendees agreed that the mainstay of pain management in the horse remains the use of non-steroidal anti-inflammatory drugs such as phenylbutazone, flunixen meglumine, and a newer entry, firocoxib. Participants reported relatively few instances
To continue reading this article, become a member of TheHorse.com.
It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.
